Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ORCODA LIMITED Capital/Financing Update 2019

Jun 25, 2019

65482_rns_2019-06-25_edd63104-987d-4f0a-aee5-eb17f60ad220.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [264 x 92] intentionally omitted <==

Orcoda Limited Unit 312, 434 St Kilda Road, Melbourne, Vic, 3004 Australia Tel +61 3 9866 7333 www.orcoda.com

ASX RELEASE 26 June 2019

Two Contracts with Key Partner Opturion Pty Ltd

Orcoda Limited (ASX: ODA) (‘Orcoda’ or ‘the Company’), the resources, healthcare, and transport logistics optimisation company, is delighted to announce that it has renewed its licence and support contract with Opturion Pty Ltd (“Opturion”). Opturion is recognised as a global innovation leader in applied optimisation AI solutions and a key provider of intellectual property that resides within the Orcoda Logistics Management System (OLMS).

The Company is also pleased to announce that Opturion and Orcoda have further entered into a separate binding teaming agreement. The teaming agreement allows the Parties to combine their respective strengths and bid for larger deals whose scale may have been unattainable without the combined efforts of both Parties.

Opturion remains one of the Orcoda’s most valued and loyal business partners. The two companies have enjoyed a sustained and enduring relationship.

Alan Dormer, Managing Director of Opturion commented, “Opturion has enjoyed a long standing, successful partnership with Orcoda, supplying 21st century optimisation technology. We are delighted that it has been extended and look forward to combining with Orcoda to deliver state-of-the-art software products and solutions to an extensive pipeline of customers in the transport, healthcare and resources sectors.”

Geoff Jamieson, Managing Director of Orcoda said, “The renewal of the licence agreement, in the context of a highly competitive market, is reflective of the confidence by the brands in each other and indicative of the aligned and exciting growth strategies of each company. The new teaming agreement allows Orcoda and Opturion to come together to assist larger clients with our unequalled optimisation solutions. This closer business relationship will help win tenders for large projects in the resources sector, particularly in relation to roster optimisation which is critical to the transportation and management of large workforces. Moving forward, we expect to see major deals in the healthcare and transport sectors as well.”

Please contact the Managing Director for any further details or information.

-ENDS-

==> picture [264 x 92] intentionally omitted <==

ABOUT ORCODA

Orcoda Limited (ASX:ODA) is a leading Australian logistics solution provider with expertise in business efficiency and optimisation of processes. We are operational efficiency specialists who supply best-inclass solutions combining software, management expertise and contracting services that makes our clients among the most productive and cost-effective organisations in their respective industries.

Our clients come from a diverse array of industry sectors and include some of Australia’s largest companies operating in the resources and infrastructure, transport and logistics and healthcare sectors.

Orcoda’s combined applications are focused on three key business sectors: healthcare, transportation and resources. We pride ourselves on enabling our clients to generate fast, accurate and reliable information, ensuring they are able to make the best business decisions the first time, every time and on time.

ABOUT OPTURION

Opturion's technology is disrupting the optimisation market and is revolutionizing the way decisions are made in transport, logistics manufacturing and maintenance. Unique 21st century optimisation technology, that utilizes artificial intelligence makes it possible to ensure compliance, reduce cost and improve customer service and productivity.

For more information please contact: Geoff Jamieson, MD +61 3 9866 7333